Navigation Links
Henry Schein To Webcast Second Quarter 2013 Conference Call On Tuesday, August 6 At 10:00 a.m. ET
Date:7/23/2013

MELVILLE, N.Y., July 23, 2013 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, announced today that it will release its second quarter 2013 financial results before the stock market opens on Tuesday, August 6, 2013, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Steven Paladino, the Company's Executive Vice President and Chief Financial Officer.

Investors can access the call through Henry Schein's Web site at www.henryschein.com, by clicking on the "Investor Relations" page and following the link for "Webcasts." For those unable to listen to the live webcast, a replay will be archived on the Henry Schein Web site.

About Henry Schein, Inc.

Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners.  The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.  A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein employs nearly 16,000 Team Schein Members and serves more than 775,000 customers.

The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care.  Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items.

The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 24 countries.  The Company's sales reached a record $8.9 billion in 2012, and have grown at a compound annual rate of 17% since Henry Schein became a public company in 1995.  For more information, visit the Henry Schein Web site at www.henryschein.com.


'/>"/>
SOURCE Henry Schein, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Henry Schein Dental And American Dental Hygienists Association Host "Dream Center" To Mark 100th Anniversary Of Profession
2. Henry Schein To Present At Three Conferences In May
3. Henry Schein Named As One Of FORTUNEs Largest 300 Corporations In America
4. Henry Schein To Webcast First Quarter 2013 Conference Call On Tuesday, May 7 At 10:00 a.m. ET
5. Henry Schein Secures $300 Million Of Committed Financing
6. Henry Schein To Open NASDAQ Stock Market in Celebration of FDI World Dental Federations "World Oral Health Day"
7. Henry Schein Named to FORTUNEs List of Most Admired Companies for 12th Consecutive Year
8. Henry Schein to Present at the 2013 Barclays Global Healthcare Conference
9. Optimer Pharmaceuticals Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
10. Henry Schein Acquires The Maddox Practice Group
11. Henry Schein, Supplier Partners Join American Dental Association On Eleventh Annual Give Kids A Smile Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2017)... Tenn. , July 31, 2017 Three Tru-D SmartUVC ... Yongsan, South Korea . Tru-D, short for "Total Room ... and operating rooms after an environmental services (ES) professional cleans the area ... ... "Although the ...
(Date:7/27/2017)... EXTON, Pa., July 27, 2017  West Pharmaceutical Services, ... financial results for the second-quarter 2017 and updated financial ... Second-Quarter 2017 Highlights Reported ... 2.5% over the prior-year quarter. Net sales at constant ... 2017 reported-diluted EPS was $0.51, compared to $0.60 in ...
(Date:7/25/2017)... BARCELONA, Spain and CAMBRIDGE, Massachusetts ... SOM Biotech, specializing in repurposing drugs to treat rare nervous ... Therapeutics Inc. to clinically develop and market the drug SOM0226 ... reached, the drug achieved very promising results in a Phase ... A new office in the United ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... August 16, 2017 , ... In 1987, McDaniel & ... years in business this year, and they’re marking the milestone by undertaking a ... their patients. , It stands to reason that, given the central importance ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... has received a three-year grant totaling $975,000, renewing its funding from the Health ... Human Services. , This funding marks, the fourth time the HRSA administration has ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards ... after every reprocessing cycle, both between patient procedures and before storage, is a ... is as important to the prevention of disease transmission and nosocomial infection as ...
(Date:8/16/2017)... ... August 16, 2017 , ... Connexion Point, a technology-enabled ... list for the fourth consecutive year. With 197% revenue growth over the ... the nation’s fastest growing companies. , Previous honors include ranking 86th on ...
(Date:8/16/2017)... TX (PRWEB) , ... August 16, 2017 , ... ... the United States, named Dr. Douglas J. Harrison, as the new Medical Director of ... be the new facility Medical Director of our Sienna Plantation location,” said Dr. Michael ...
Breaking Medicine News(10 mins):